Hear AtLast Holdings, Inc. (HRAL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -234.36 Thousand USD | -8.89% |
| 2022 | -215.23 Thousand USD | 71.9% |
| 2021 | -765.95 Thousand USD | -134.74% |
| 2020 | -326.3 Thousand USD | 59.78% |
| 2019 | -811.2 Thousand USD | -26940.0% |
| 2018 | -3000.00 USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | -100.0% |
| 2014 | 1.58 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -112.73 Thousand USD | -72.48% |
| 2023 Q4 | -65.35 Thousand USD | -20.99% |
| 2023 FY | -234.36 Thousand USD | -8.89% |
| 2023 Q3 | -54.02 Thousand USD | -65.97% |
| 2023 Q2 | -32.54 Thousand USD | -60.97% |
| 2023 Q1 | -20.22 Thousand USD | 8.79% |
| 2022 Q4 | -22.16 Thousand USD | 56.75% |
| 2022 Q3 | -51.25 Thousand USD | 63.37% |
| 2022 Q1 | -1910.00 USD | 99.31% |
| 2022 FY | -215.23 Thousand USD | 71.9% |
| 2022 Q2 | -139.9 Thousand USD | -7224.76% |
| 2021 Q3 | -68.16 Thousand USD | -34.28% |
| 2021 Q4 | -278.58 Thousand USD | -308.71% |
| 2021 Q2 | -50.76 Thousand USD | 63.69% |
| 2021 Q1 | -139.8 Thousand USD | -1584.62% |
| 2021 FY | -765.95 Thousand USD | -134.74% |
| 2020 Q2 | -324.49 Thousand USD | -2016.6% |
| 2020 Q3 | -13.44 Thousand USD | 95.86% |
| 2020 Q4 | -8299.00 USD | 38.27% |
| 2020 Q1 | -15.33 Thousand USD | 97.24% |
| 2020 FY | -326.3 Thousand USD | 59.78% |
| 2019 Q4 | -556.25 Thousand USD | -736.47% |
| 2019 FY | -811.2 Thousand USD | -26940.0% |
| 2019 Q2 | -87.61 Thousand USD | 13.1% |
| 2019 Q1 | -100.83 Thousand USD | 51.2% |
| 2019 Q3 | -66.5 Thousand USD | 24.1% |
| 2018 FY | -3000.00 USD | 0.0% |
| 2018 Q4 | -206.61 Thousand USD | -27449.07% |
| 2018 Q2 | -1500.00 USD | 0.0% |
| 2018 Q3 | -750.00 USD | 50.0% |
| 2017 FY | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 FY | - USD | -100.0% |
| 2014 FY | 1.58 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 74.715% |
| Ansell Limited | 76.5 Million USD | 100.306% |
| Ansell Limited | 76.5 Million USD | 100.306% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 24.28 Million USD | 100.965% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 85.624% |
| Psykey, Inc. | -1.32 Million USD | 82.298% |
| ConvaTec Group Plc | 130.3 Million USD | 100.18% |
| ConvaTec Group Plc | 130.3 Million USD | 100.18% |
| Encision Inc. | -691.78 Thousand USD | 66.121% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -65.266% |
| Innovative MedTech Inc. | -7.93 Million USD | 97.048% |
| LifePoint, Inc. | -15.23 Million USD | 98.461% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 96.559% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 50.556% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 14.604% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 48.943% |
| SmileDirectClub, Inc. | -86.4 Million USD | 99.729% |
| Sector 10, Inc. | 7036.00 USD | 3430.955% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 100.012% |
| SheerVision, Inc. | -71.37 Thousand USD | -228.354% |
| United Health Products, Inc. | -2.62 Million USD | 91.066% |
| Vasamed, Inc. | -4.88 Million USD | 95.205% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 90.188% |
| Yubo International Biotech Limited | -1.2 Million USD | 80.547% |